TTG50 Winner: Health
Tech Tour Growth 50 2022
Digital Health 150
CB Insights 2021
HSJ Partnership Award 2022
Most Impactful Project Addressing Health Inequalities
Join us at Best Practice 2022
We are excited to be attending the Best Practice Show in Birmingham on 12-13 October 2022, and we hope to see you there!
Visit us at stand E125
Let us buy you a coffee at the conference when you book a chat with one of our friendly team. We’ll also be holding demos of our unique digital tools, running prize draws, and looking to chat about the challenges faced by primary care in your local area.
Grab your ticket here. This event is free for healthcare, allied healthcare, NHS, social care, public sector professionals so it’s not one to miss!
If you’re not going to the conference, don’t miss out on our latest news and events by following us on Twitter, Linkedin or signing up here.
Attend our presentation
Technology is fast reshaping the health landscape, allowing for greater access, greater uptake and in return greater outcomes. With significant potential for further transformation, digital technologies are vital to achieve many of the goals in the NHS long-term plan. While we need to question whether this offers personalised care, we also need to be open to the value technology will bring to both patients and primary care.
Join Lucy Jones RD as we discuss if digitally-enabled healthcare can really provide patient-centred care.
12.15-12.45pm Wednesday 12 October 2022
What does Oviva do?
Oviva helps prevent and treat health conditions related to diet & lifestyle, such as obesity, Type 2 diabetes, undernutrition and cow’s milk allergy. Our programmes deliver a superior patient experience while saving the NHS money. We achieve this through hyper-personalised programmes for the patient that combine support from healthcare professionals with effective content, and can be accessed in-person or remotely.
Diabetes Prevent
-4.54kg
Average weight loss achieved at 9 months
Diabetes Prevent
| Uptake from referral | 79% |
| Average weight loss at 9 months | -4.54kg |
| Participants with BMI>30kg/m2 lost more than 5% body weight | 28% |
For more information about our clinical outcomes for Diabetes Prevent, please contact us.
Diabetes Support
-14mmol/mol
Average HbA1c reduction
Diabetes Support
| Average uptake from referral | 73% |
| Average body weight reduction | -3.7kg |
| Average HbA1c reduction | -14mmol/mol |
| Likely/extremely likely to recommend in Friends and Family test | 100% |
| Average completion rate | 73% |
Diabetes Remission
-14.7kg
Average body weight reduction at 12 months
Diabetes Remission
| 12 week Total Diet Replacement completion rate | 93% |
| Average body weight reduction at 12 months | -14.7kg |
| Average HbA1c reduction | 33% |
| Prescriptions stopped on average per participant | 3.3 |
| Average rate of Type 2 diabetes remission | 63% |
Weight Management
-9.2kg
Average body weight reduction at 6 months
Weight Management
| Uptake from referral | 89% |
| Average body weight reduction at 6 months | 9.2kg |
| Difference in weight loss between face to face and remote treatment | 0 |
| Completion rate | 88% |
Adult nutrition support
£425
Average cash-releasing saving per patient on Oral Nutrition Supplements
Adult nutrition support
| Overall estimated annualised saving per patient | £716 |
| Average cash-releasing saving per patient on Oral Nutrition Supplements | £425 |
paediatric allergy
-35%
Reduction in spend on infant milk products
paediatric allergy
| Parents who rated their experience as good or very good | 100% |
| Reduction in spend on infant milk products | -35% |
| Infants who successfully passed the milk reintroduction phase | 35% |
Stay in touch
Keep up-to-date with all of our latest news and events by entering your details.